Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antibody”

426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 426
Index total 30,257
Page 15 / 18

Quick answer

This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

426 results for “antibody” · 30,257 patents in full index Clear search

  1. US 8637031

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  2. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  3. US 8628782

    Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  4. US 8617557

    Antibody fusion with IL-12 proteins with disrupted heparin-binding activity

    The Regents of the University of California · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  5. US 8580927

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  6. US 8568721

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  7. US 8563269

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  8. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  9. US 8557245

    Methods for treating bone cancer by administering a nerve growth factor antagonist antibody

    Regents of the University of Minnesota · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  10. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  11. US 8524239

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  12. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  13. US 8501423

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  14. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  15. US 8425907

    Methods for treating pruritus by administering an antibody that specifically binds human PAR2

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  16. US 8404817

    Humanized anti-prostate stem cell antigen monoclonal antibody

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  17. US 8361471

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  18. US 8337848

    Monoclonal antibody for APP

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  19. US 8329873

    Bispecific single chain Fv antibody molecules and methods of use thereof

    The Regents of the University of California · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  20. US 8329181

    Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  21. US 8309088

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

  22. US 8258263

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  23. US 8232068

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  24. US 8192741

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.